Faraday Future Invests $41M in Qualigen to Boost Crypto and Growth Initiatives
Faraday Future invests $41 million in Qualigen Therapeutics to support its expansion into crypto and Web3, with plans to rebrand QLGN as CXC10 and focus on integrating Web2, Web3, AI, and crypto technologies, aiming to become a leading U.S. public company in this space.